UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000004061 |
|---|---|
| Receipt number | R000004867 |
| Scientific Title | A phase II study of Bortezomib for relapsed/refractory adult T-cell leukemia/lymphoma (ATL) |
| Date of disclosure of the study information | 2010/08/18 |
| Last modified on | 2017/10/03 21:52:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/08/18 11:51:07 | ||
| 2 | Update | 2011/09/27 15:47:54 | Organization Organization Category of Funding Organization Name of secondary funder(s) Name of secondary funder(s) Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2012/02/18 15:05:02 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
| 4 | Update | 2012/03/22 10:55:01 | ||
| 5 | Update | 2012/03/22 10:56:46 | Institutions |
|
| 6 | Update | 2012/03/22 10:58:08 | Organization3 Address3 Tel3 Email3 |
|
| 7 | Update | 2013/02/13 23:06:20 | Institutions |
|
| 8 | Update | 2013/02/13 23:08:55 | Last follow-up date |
|
| 9 | Update | 2013/10/19 17:10:17 | Email Institutions |
|
| 10 | Update | 2014/03/18 22:41:25 | Recruitment status Last follow-up date |
|
| 11 | Update | 2015/02/18 11:46:48 | Recruitment status Last follow-up date |
|
| 12 | Update | 2017/10/03 21:52:45 | Publication of results Results |
